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1. Introduction
Upper urinary tract endoscopy has come a long way from the first endoscopic examination
performed in 1912 by Young and McKay. They used a 9.5 F rigid cystoscope in a patient
with a very dilated ureter [1]. Current semi-rigid and flexible instruments are purposely de‐
signed to allow diagnostic and effective therapeutic interventions with minimal associated
morbidity. The timeline of this evolution is perfectly described elsewhere [2].This chapter
summarises the instrumentation available to the modern urologist, the basic principles be‐
hind their use and the major clinical outcomes now expected from their use.
2. Technology
This section will describe the endoscopes in modern use and the ancillary equipment we use
for therapeutic indications. While some units still use a rigid ureteroscope these have been
replaced in many units by semi-rigid and flexible ureteroscopes.
2.1. Endoscopes
2.1.1. Semi-rigid
The semi-rigid ureteroscope is the workhorse of endoscopic ureteric surgery. It was devel‐
oped from the larger rigid ureteroscope primarily because of concerns about the inability of
the rigid scope to access the upper ureter without causing significant damage to the urothe‐
lium. The “flexibility” and reduced size are primarily due to the introduction of fibre-optics.
© 2013 Naidu et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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The fibre-optic bundles (clad for image transmission, unclad for light transmission) are fixed
at both ends which permits movement without loss of picture quality.
Modern scopes have either straight (Figure 1) or offset eyepiece. The only advantage of the off‐
set eyepiece is that it allows the use of larger therapeutic instruments.The shaft is usually ta‐
pered so that the distal diameter (4.5 – 9 F) is less than the proximal (6.5-15F). The difference
between proximal and distal diameter varies between manufacturers but is of the order of 2-4
F. The scope length is described as being “short” at approximately 30 cm or long at 40+ cm.
Short scopes are useful for the lower ureter in males and lower and upper ureter in females. The
long ureteroscope is best for visualisation and treatment in the upper ureter.Within the metal‐
lic sheath are the fibre-optic bundles and either one or two working channels. If two channels
are being used, one tends to be larger to allow instrumentation and either continued of irriga‐
tion or a second working instrument.The distal end tends to be ovoid (figure 2). A variety of ac‐
cessories are available to improve irrigation flow but the vast majority of procedures are done
using gravity, either alone or using pressurised irrigation bags.
Figure 1. Headpiece of modern semi-rigid Ureteroscope. This model has a straight eyepiece with two working chan‐
nels each with a red rubber seal. In this model both channels are equal in diameter.
Figure 2. Distal tip of a semi-rigid ureteroscope showing the larger opening of the working channels (right side) com‐
pared to the optical opening. Note the stepped appearance as opposed to a more usually seen tapered tapered ap‐
pearance. The lens is angled at 5 degrees to allow visualisation of the working instruments as they exit the channel.
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Semi-rigid ureteroscopes are very durable instruments. The biggest reason for failure is im‐
proper use or maintenance. Factors associated with failure are age, shaft design (tapered <
stepped) length (long > short) and diameter (narrow > wider). While the instruments flexi‐
bility has increased its therapeutic potential, it also increases its susceptibility to breakage
and deflections above 5cm are said to be particularly damaging to the instruments [3-4].
Figure 3. An Olympus flexible ureteroscope (single active deflection, one thumb handle) and Wolf semi-rigid uretero‐
scope.
2.1.2. Flexible ureteroscopy (figure 3)
2.1.2.1. Historical perspective
The first flexible ureteroscope was introduced through a ureterotomy at open surgery in
1960 [5]. The first trans-urethral instrument was used in 1962 to treat a stone in the lower
ureter. This instrument and its immediate successor were diagnostic instruments which
could not be manoeuvred. In addition they required forced diuresis to keep the ureter pat‐
ent. A group from the University of Chicago pioneered the next major developments to in‐
corporate a deflecting tip. This instrument still required insertion into the ureter through a
rigid channel but was the first flexible ureteroscope to resemble a modern instrument [6].
The same group were the first to trial an actively deflecting flexible ureteroscope and intro‐
duced secondary passive deflection to produce the modern ureteroscope [7].
2.1.2.2. Modern design
The basic design of the instrument is similar to the semi-rigid instrument.Each uses non-co‐
herently arranged light bundles for light transmission (flexi uses 1-2 only) and coherently
arranged bundles for image transmission (flexi uses one). Likewise there is a working chan‐
nel (one) which is usually 3.2 F diameter. In the flexible scope this is cylindrical and situated
slightly off-center. This is because of the fibre-optics for image transmission.The degree of
eccentricity of the working channel is greater with increasing diameter and results in a dis‐
proportionate larger loss of deflection when using instruments. A further loss of deflection
ability comes from using “stiffer” instruments.The flexible ureteroscope is also hard wearing
but rather than drawing its strength from steel column strength comes from composite poly‐
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meric materials. They also come in variable lengths (54 – 70 cm) and are tapered with a dis‐
tal end of 4.9 – 11 F (most 5.3 – 8.7) and a proximal diameter of 5.8 – 11F(most 7.7-9.9).
2.1.2.3. Differences between semi-rigid and flexible ureteroscopes
The essential difference between the two types of ureteroscope are in terms of optics and
ability to deflect. The fibre-optic bundles are smaller in the flexible scope. This usually does
not adversely impact on light intensity because of the higher refractive index of the bundles.
The angle of view is altered by fitting the distal bundles with an angled lens. Usually this is
up to 10° and allows visualisation of instruments as they exit the working channel. The
depth of view is less in the flexible scope due to fibre-optic technology, this is compensated
for by magnification and focusing. This is a feature common for all flexible endoscopy.
The major difference between the two types of ureteroscope is in the degree of movement
available with the flexible instrument. The initial range of deflection was up to 170°. This
was based on the measurement of the maximum uretero-infundibular angle [8]. The most
modern ureteroscopes can deflect to 270° both sides.
Deflection is sub-divided into active and passive deflection.Active deflection is controlled by
a lever mechanism just behind the eyepiece. The basic principle behind this is that moving
wires which pass through the scopes cladding and which are fixed to the distal tip causes
the scope to bend. Where one lever is present this is called primary active deflection. The
most modern scopes have a second active deflection mechanism (figure 4). Passive deflec‐
tion is facilitated by a “softer” segment of the ureteroscope which on contact with the curves
of the intra-renal collecting system allows the scope to be deflected. This allows inspection
of and treatment in all parts of the collecting system.
Figure 4. Cartoon depicting deflection in a flexible ureteroscope. The softer segment (**) is represented in red and is
the point at which the flexible ureteroscope “bends” on contact with the urothelium. The single * represents the point
of primary active deflection and the double ** represents the point of secondary active deflection.
Not surprisingly the flexible ureteroscope does not have the same longevity as the semi-rig‐
id ureteroscope and the cost of repair is about twice that of a semi-rigid ureteroscope. The
risk factors for damage are increasing length and decreasing diameter of flexible uretero‐
scope, instrument or laser damage to the working channel or overzealous deflection within
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the collecting system especially with an instrument in situ[4]. Pietrow et al have looked at
factors to increase the lifespan of flexible instruments. The instrument should be stored with
the headpiece upright and the tip dependent. At no time should the shaft be bent, as to do
so risks damaging the light bundles. This damage is evident as black dots within the image.
When inserting instruments it is best to ensure that the tip is straight and a laser should not
be activated until the tip of the fibre is about two mm from the telescope. As repeated inser‐
tion can be damaging it is thought that access sheaths can prevent damage. The use of softer
wires (eg Nitinol) and smaller calibre laser fibres can also help [9].
2.2. Ancillary technology
These are the instruments and technology which turn the instrument from a diagnostic tool
into a potent therapeutic modality.
2.2.1. Tissue / stone destruction
There are four techniques for stone destruction in use in Urology. Of these two (laser and
EHL) are most widely used in ureteric and intra-renal endoscopy.Electro-Hydrolic Litho‐
tripsy (EHL) uses the cavitation bubble produced by an electrically induced spark to destroy
calculi. This is achieved by the expansion of the bubble resulting in a shock wave, followed
by its collapse and rebound off any surface with which it comes into contact. Using a 5F
probe up to 90% of ureteral calculi can be successfully treated. The advantage of this tech‐
nology is that it is relatively inexpensive with low running costs. The disadvantage is that,
because of the uncontrollable nature of the shock wave, fragments are propelled forward.
This is also the explanation for the ureteric perforation rates of up to 8.5% [10].For best re‐
sults the probe should be held at a minimum distance of 1 mm from the stone and 1-2 mm
from the ureteroscope and urothelium.
Ultrasound, pneumatic and EHL sources are useful only for treating calculi. Hence for treat‐
ment of upper tract lesions or haemostasis for biopsy other technologies are required. Con‐
tact diathermy probes are available but are limited by size to treating ureteric and renal
pelvic lesions. Their use with a flexible ureterorenoscope limits deflection.
The primary energy method used in endourological management of both stones and small
volume upper tract TCC is LASER. While many laser types have been used the main laser
used is the Holmium: YAG laser (figure 5). The primary reason for this is that it is the only
laser capable of destroying any stone type. The Holmium is a solid state pulsed laser with a
wavelength of 2100 nm and delivers the enrgy through quartz fibres. The fibres range in size
from 200 – 1000 μm. In our unit we use a 270 and 365 μm fibre both of which can be used
through a semi-rigid and flexible ureteroscope. Most lasers use an acoustic shock wave (sim‐
ilar to EHL) generated by vaporising the fluid in front of the fibre creating a gas bubble.The
Holmium laser does produce vaporisation but its primary effect is photo-thermal thus effec‐
tively evaporating the stone or tissue [11]. This produces tiny fragments of approximately
the same size as the fibre. This is in contra-distinction to other energy forms which produce
uneven larger fragments. However retro-pulsion of fragments can occur being seen most
Modern Upper Urinary Tract Endoscopy
http://dx.doi.org/10.5772/52750
367
with larger fibres. Like EHL, the holmium laser can damage urothelium and perforate the
ureter. However this requires direct contact with the urothelium as because of its high ab‐
sorption in water the laser energy penetrates no more than 1 mm into hydrated tissue. It has
been estimated that this contact time is of the order of two seconds [12].
Figure 5. A holmium laser in use on an intra-renal stone at semi-rigid ureteroscopy.
2.2.2. Anti-migration devices
As indicated above one of the biggest problems withtreating stones in the ureter is retropul‐
sion. There have been a number of approaches to reducing this migration. The most com‐
mon approach is to place a device beyond the stone in a closed manner. Once past the stone
the device is deployed to form a barrier to retrograde stone passage.The most used exam‐
ples of this are the Stone cone © (Boston Scientific) (figure 6) and the N-Trap (Cook Medi‐
cal). The Stone Cone is a Nitinol based wire with a length which is softer and forms a conical
shaped when deployed. It is straightened by passing it over a wire and assumes its natural
shape once the wire is removed. The N-Trap when deployed from its access sheath forms a
basket. Laser lithotripsy is then performed and any fragments which migrate upwards do so
into the Cone/Basket. At the end of the lithotripsy procedure, the Cone/Basket is gently re‐
moved under vision with the ureteroscope. Both devices are designed to release a stone
fragment when a threshold level of pressure is reached. This prevents larger fragments im‐
pacting in the ureter at attempted removal.
Figure 6. The Stone Cone (Boston Scientific) in its “cone” shape prior to use.
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A newer approach is to inject a liquid polymer above the stone which on exposure to body
temperature solidifies. This forms a seal or plug which prevents migration. Once the stone is
destroyed cold saline irrigation is used which liquefies the gel. The polymers construction is
such that any residual gel is degraded and gone from the ureter by two hours. The only
commercially available model is the Backstop from Boston Scientific.
2.2.3. Baskets and graspers
These come in multiple shapes and sizes with the primary aim of grasping or trapping the
stone fragments. This allows physical removal of the fragments. Graspers tend to have three
prongs which facilitates extraction of “larger” fragments. They tend to have a co-axial de‐
sign with inner and outer sheaths. Retrieval is facilitated by advancing the inner sheath. Bas‐
kets are designed to trap multiple small fragments within their Nitinol wires. There are
various designs with varying features aimed at improving the stone free rate post lithotrip‐
sy. Tipless designs are said to reduce the risk of urothelial perforation. A recent trend is the
basket in which laser lithotripsy can be performed with the laser fibre being introduced
through the hollow shaft (eg Cook Flat wire stone extractor).
Figure 7. A re-usable ureteroscopic biopsy forceps (left) and a tri-radiate grasper (Captura, Cook medical)
2.2.4. Biopsy forceps
These instruments are a standard part of the endourologists arsenal. They are used for for‐
eign body removal in the case of a migrated JJ stent. Also they are useful for biopsy of intra-
ureteric lesions for histological evaluation. However because of size constraints resultant
from the dimensions of the ureteroscope, they are very small and the biopsy sample attained
is often too small for analysis. A solution to this was developed by Cook. They backloaded a
larger biopsy forceps (Bigopty) through the ureteroscope and then connected it to the biopsy
handle. The biopsy forceps thus enters the ureter before the ureteroscope and hence can be
of greater size (figure 8).
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Figure 8. Bigopty (Cook Medical), a backloaded ureteric biopsy forceps,capable of taking large biopsy samples.
3. Ureteroscopy technique
All uretersocopy is preceded by a careful cystoscopy. A negative MSU or treatment with
culture appropriate antibiotics is mandatatory. Active infection is the only absolute contra-
indication to ureteroscopy. Relative contra-indications are ongoing anti-coagulation therapy
or bleeding diatheses. Appropriate antibiotic prophylaxis is given at induction of anaesthe‐
sia. This has been shown to reduce infection rates from 13 to 2% [13].Ureteroscopy is usually
under a general / spinal anaesthetic with the patient in the lithotomy position but can also be
performed in the flank or prone positions.Some authors suggest that the ipsilateral leg be
straightened to facilitate ureteral entry.A careful cystoscopy prevents bleeding from the
bladder neck which can impair vision and identifies situations where ureteral access is more
difficult such as the man with a median lobe or high bladder neck. The primary aim of the
cystoscopy is to insert a 0.035 to 0.038 inches guidewire (“floppy” end first) into the relevant
ureteric orifice which facilitates the safe introduction of the semi-rigid ureteroscope. This is
placed into the renal pelvis under fluoroscopy so that the floppy end is seen to be coiled.
This wire is typically called the “safety” wire. Should this prove difficult, the bladder should
be emptied and a further attempt made. If it still proves difficult a ureteric catheter can be
used to straighten the intra-mural ureter (figure 9). This usually allows the wire to pass. The
bladder is emptied on completion to avoid distortion of the ureteric orifice and minimise
kinking of the intra-mural ureter.
3.1. Semi-rigid ureteroscopy (AUA and EAU guidelines, ref 14-15)
The initial step is introducing the ureteroscope into the ureteric orifice. The tip of the scope
can be passed under a ”safety” guidewire to facilitate entry. If this does not permit entry
then the scope should be rotated. Should this fail a second wire can be introduced and the
tip of the scope passed between the two wires. This is called “rail-roading” (figure 10). If this
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does not work then the next step is dilatation of the ureteric orifice and should that fail then
a JJ stent is placed. This results in dilation by loss of peristalsis. Interval ureteroscopy can
then be performed after approximately two weeks.
Figure 9. Use of a ureteric catheter (white tube) to facilitate entry into the left ureteric orifice in a man with a median
lobe of prostate and a high bladder neck.
A longer ureteroscope is needed in males due to the combination of the longer urethra, the
relatively immobile prostatic urethra and the better development of the Psoas muscle. The
latter factor can make it difficult to negotiate the ureteroscope beyond the iliac vessels. A
second wire can sometimes help straighten a tortuous ureter. However, excessive force
should be avoided because of the risk to the ureter (mucosal damage, perforation) and to the
ureteroscope because of shear forces.
Figure 10. View from a ureteroscope as it is being inserted into the left ureteric orifice between two guidewires (rail‐
roading)
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3.2. Flexible ureteroscopy (AUA and EAU guidelines ref 14-15)
Most flexible ureteroscopy is preceded by a semi-rigid examination of the ureter. This
amongst other things dilates the ureteric orifice as well as allowing placement of a second
guidewire. This second wire usually straightens out the ureter. There are two schools of
thought on flexible ureteroscopic technique. One will introduce the flexible scope into the
urethra and either beside or loaded along the guidewire into the ureteric orifice. The other
will use a ureteric access sheath to allow repeated easy access to the ureter. A ureteric sheath
(figure) is placed over a stiff guidewire under screening to the lower or mid ureter depend‐
ing on the level at which the operator needs to work. The flexible ureteroscope is then
placed through the sheath directly into the ureter. Where repeated insertions/removals are
necessary, the access sheath reduces instrumentation time. The advantage of using the
sheath is that it may reduce the intra-renal pressure during prolonged stone procedures
hence minimising the risk of nephron loss.Once in the collecting system, the flexible uretero‐
scope can be manoeuvred to directly visualise all calyces. This is by a combination of torqu‐
ing (twisting) the scope itself and active and passive deflection. Visualisation of the calyces
is helped by retrograde contrast injection and radiological screening, thus outlining the
whole system.
3.3. Complications of ureteroscopy (specific to ureteroscopy)
Ureteroscopy is performed in the lithotomy position. This position increases the risk of DVT
and for this reason most endourologists use compression boots. The risk is small with mod‐
ern series reporting a risk of 0.2%. The other risk of positioning is damage to nerves such as
the common peroneal through inadequate padding. Thankfully the risk is very small and
the damage is usually temporary.
Ureteric complications range in severity from bleeding to complete avulsion. Bleeding is
usually self limiting and occurs following instrumentation. Its reported in 0-2.1 % of series
and usually does not prevent procedure completion. The majority will settle with an indwel‐
ling JJ stent/ ureteric catheter for at most two weeks. More significant ureteric damage re‐
sults in either a tear or perforation. A tear is defined as a breach in the urothelium. It is best
to move any stone away fro the tear into dilated ureter to prevent further damage. Again
they usually respond to a short period of stenting. Ureteric perforation occurs in one to five
percent of modern studies. The rate is decreasing due to increasing experience and (more
significantly) smaller calibre instruments.Stenting is the mainstay of management and it is
in this situation that the safety wire really helps. The stent can be placed over the safety wire
which has been pre-positioned into the renal pelvis. If the patient does not settle or develops
an infected urinoma then a percutaneous nephrostomy may have to be placed.It is excep‐
tional to require open repair of a perforation.
Ureteric intussusception (urothelium only, muscle in place) and avulsion are the most se‐
vere forms of ureteric injury. Both are due to overly aggressive attempts to remove stone
fragments or to forcing a ureteroscope through a narrowed ureteric segment. The golden
rule is to stop and re-evaluate. In the case of a ureter which will not accept a scope then the
narrowed are can be dilated under radiological screening or a JJ stent can be left for a period
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of four weeks. The stent causes ureteric dilation and ureteroscopy can usually be completed
at the time of stent removal. In the situation where a stone laden basket will not negotiate a
narrowed area then it should be gently moved back up to dilated ureter and opened. This
will release some fragments and permit a further attempt at removal. If this fails it means
that the fragments are too large and further laser lithotripsy is warranted. If the basket will
not open then it can be disassembled and laser lithotripsy performed to the fragments with‐
in the basket.If either avulsion or intussusception is suspected then an immediate retrograde
examination is performed. If the renal collecting system is not outlined with contrast then
the diagnosis is confirmed. Drainage of the collecting system is mandatatory and this is usu‐
ally with a percutaneous nephrostomy. Open surgery is required and the technique used
will depend on the site and extent of injury.
4. Upper tract stones
4.1. Introduction
Between 1200 and 1400 per 100,000 people will develop urinary stones each year with a
male:female ratio of 3:1.The majority of stones are composed of calcium oxalate, often mixed
with calcium phosphate, in both adults and children. The acute presentation is usually un‐
mistakable with the classical history of loin to groin colicky pain. Evaluation with non-con‐
trast CT is advisable for diagnosis. The immediate management usually involves analgesia
and treatment of any infection present, and then determining definitive management [14].
Stones smaller than 5 mm will generally pass, but larger stones often require urological in‐
tervention [16]. For the purpose of this chapter, the management of upper urinary tract
stones will be explored and outlined with the emphasis being on endourological manage‐
ment.
4.2. Management
The options available for the management of upper urinary tract stones include observation,
Extra-Corporeal Shock wave Lithotripsy (ESWL), Ureteroscopy, Percutaneous Nephro-lith‐
otomy (PCNL),laparoscopy and rarely open surgical removal. The appropriate modality for
each individual patient will depend on the interaction between stone (size, location, appear‐
ance of the stone on imaging, composition),anatomical abnormalities, the presence of infec‐
tion and concomitant co-morbidities which may affect the decision regarding appropriate
anaesthetic time.There also is an increasing trend toward intervention because of technologi‐
cal improvements and a growing dissatisfaction with the overall success rates with extracor‐
poreal shock wave lithotripsy [17].
Most stones less than 5mm in size will pass spontaneously.European Association of Urology
guidelines state that active stone removal is recommended for renal stones >6-7mm in size
[14]. However, those of less than 6mm in size, if symptomatic, can be considered for treat‐
ment [14-15].
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4.2.1. Non invasive treatment of upper tract stones
ESWL is entirely non invasive, and it uses super sonic waves to fragment stones into small
pieces that can be easily passed. Shortly after its introduction in 1983, it became widely ac‐
cepted as the first line treatment modality for the majority of stones and rapidly replaced
invasive surgical options. ESWL is effective for most renal stones less than 2 cm in size and
ureteric stones less than 1 cm in size [18].In patients with normal anatomy, and with non
lower pole renal stones < 20mm in size, ESWL is recommended as first line treatment. Lower
pole stones have a higher failure rate with ESWL and so other treatment modalities should
be sought ( see below). In one study which compared stone free rates of ureteral stones of
variable sizes and locations which were treated by ureteroscopy or extra-corporeal shock
wave lithotripsy, ESWL was associated with a success rate of 64% ( up to two treatments), as
compared to 96% for ureteroscopy in a single treatment [17].
It is important to highlight that certain stone composition such as cystine or phosphate
stones may be resistant to fragmentation.There are also multiple other contra indications to
the use of ESWL which include pregnancy, bleeding diatheses, severe obesity, anatomical
obstruction distal to the stone.
4.2.2. Invasive treatment of upper tract stones
Larger stones, particularly those composed of cystine or struvite, can be approached via es‐
tablishing percutaneous access to the collecting system through a small flank incision. This
would allow direct visualization and intra-corporeal lithotripsy for stone disruption, and re‐
moval of fragments known collectively as Percutaneous nephrolithotomy (PCNL).
PCNL has high success rates of around 90% however there are risks onvolved, and major
intra-operative or post operative complication rates are often reported as 0.03% to 10% [19].
However, ureteroscopy is fast becoming the main form of treatment for upper urinary tract
stone management and this is what will be discussed for the purpose of this chapter.
4.2.3. Selecting the treatment for a patient with stone management
Intra-renal calculi
Different stone sizes respond better to different therapies and success rates are variable for
the size of stone. The European Urological Association recommends the following manage‐
ment plan for kidney stones in the renal pelvis or upper/middle calyx, categorised according
to size:
Flexible ureteroscopy is used less as a first line treatment for stones > 1.5cm in size. However
with ongoing improvements in newer generation flexible ureteroscopes, there is an increas‐
ing trend toward ureteroscopy and laser lithotripsy for intr-renal calculi of all sizes and
compositions. In the available literature, there are very few reported studies on the use of
semi rigid ureteroscopy to treat renal stones. A prospective analysis performed by Bryniar‐
ski and co-workers assessed the safety of PNCL and retrograde intrarenal surgery use semi
rigid ureteroscopy for the management of renal stones of >2cm in size. Although stone free
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rates were superior in the PCNL group, the semi rigid ureteroscopy provides advantages for
operating times, haemoglobin loss, post-operative visual analogue scoring by patients and
reduced hospital stay [20]. The situation is slightly more complex in lower pole stones as the
following table shows.
Stones <1cm in size Stones 1-2cm in size Stones >2cm in size
ESWL ESWL or endourology Endourology (PCNL / flexible
ureteroscopy)
Flexible ureteroscopy ESWL
PCNL Laparoscopy
Table 1. European Association of Urology (EAU) recommendations for the treatment of Renal stones.
Treatment for renal calculi in the inferior calyx is also very dependent on size:
Stones <1cm in size Stones 1-2cm in size Stones >2cm in size
ESWL Favourable factors for ESWL? Endourology ( PCNL or
ureteroscopy)
Flexible ureteroscopy No -> Endourology
PCNL Yes -> ESWL or endourology
Table 2. EAU recommendations for the treatment of Lower pole stones.
Ureteric Calculi
The management of ureteric calculi is also dependent on the size of the stone involved. The
table below outlines the European Urological Association guidelines for Stone management
dependent on size of stone:
Location Stone size 1st choice 2nd choice
Proximal ureter <10mm
>10mm
ESWL
Ureteroscopy (retrograde or
antegrade) or ESWL
Ureteroscopy
Ureteroscopy (retrograde or
antegrade) or ESWL
Distal ureter <10mm
>10mm
Ureteroscopy or ESWL
Ureteroscopy
Ureteroscopy or ESWL
ESWL
Table 3. EAU recommendations for the treatment of Ureteric stones
The outcomes of ureteroscopy
The European Association of Urology and the American Urological Association guidelines
Panel have published stone free rates for different treatment modalities within their nephro‐
lithiasis guidelines.In a cohort comparison group (early 1980s vs 1992) the success of ure‐
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teroscopic procedures rose from 86% to 96%. In addition, they observed an overall decrease
in complications (20% to 12%) in ureteroscopy and 6.6% to 1.5% in ureteroscopic laser litho‐
tripsy [21]. Partly, this was thought to be due to greater surgeon experience and that this is
significantly correlated to higher success and lower complication rates in ureteroscopic laser
lithotripsy with holmium laser [21].
Renal Calculi
The success rates (stone free or insignificant fragments) reported with PCNL are greater
than 90% for renal stones >2cm. However, major complications during or after PCNL occur
at reported rates of 0.03 % to 10% [22]. The success rates of retrograde intra-renal surgery
have been reported as 75-95% for intra-renal stones >2cm after the first or second treatment,
whereas the major or minor complications vary from 1.5 % to 12% [23].This is less frequent
than rates in PCNL procedures. Major complications in ureteroscopy such as ureteric perfo‐
ration or avulsion are extremely rare.
Ureteric Calculi
One study of a two year experience, highlighted that the success rates following ESWL were
heavily influenced by stone size.The overall stone free success rate was 74.7% with one ses‐
sion. However, as the size of the stone increased, the success rate reduced. For stones <1cm
the success ratewas 83.6%and when the stone size > 1cm the success rate reduced to 42.1%.
The stone free rates also varied according to the site of the stone - 72.4% (proximal), 70%
(mid ureter), and 82% (distal) after a single session [14-15].
In ureteroscopy, an overall stone –free rate of 87.8% was obtained irrespective of the size of
the stone (88.9% for <1cm and 86.6% for >1cm). The success rates did slightly vary in relation
to the stone site. The stone-free rates were 75% (proximal), 94.6% (mid ureter) and 84.6%
(distal) [24].
The American Urological Association recent 2012 guidelines have published stone free rates
for Shock Wave lithotripsy and ureteroscopy for the treatment of ureteric calculi and these
are outlined in the tables below:
Proximal ureter:
Treatment Overall Stone size < 10mm Stone size >10mm
ESWL 82% 90% 68%
Ureteroscopy overall
Flexible ureteroscopy
81%
89%
80%
84%
79%
Table 4. Proximal Ureter; stone clearance comparison between Ureteroscopy and ESWL.
Mid Ureter:
The reduced success for stone free rates using ESWL in the mid ureter is likely explained by
the anatomical changes at this site. The mid-ureter is closely related to the transverse proc‐
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esses of the lumbar verterbrae and focus of the lithotripsy beam is more difficult due to the
anatomical relationships to the spine.
Treatment Overall Stone size < 10mm Stone size >10mm
ESWL 73% 84% 76%
Ureteroscopy overall
Flexible ureteroscopy
86%
88%
91%
Not documented
78%
Not documented
Table 5. Mid Ureter; stone clearance comparison between Ureteroscopy and ESWL.
The reduced success for stone free rates using ESWL in the mid ureter is likely explained by
the anatomical changes at this site. The mid-ureter is closely related to the transverse proc‐
esses of the lumbar verterbrae and focus of the lithotripsy beam is more difficult due to the
anatomical relationships to the spine.
Distal ureter:
Treatment Overall Stone size < 10mm Stone size >10mm
ESWL 74% 86% 74%
Ureteroscopy overall
Rigid ureteroscopy
94%
94%
97%
98%
93%
94%
Table 6. Distal Ureter; stone clearance comparison between Ureteroscopy and ESWL.
The use of holmium laser lithotripsy via ureteroscopy is safe and effective in urinary stone
management, particularly for larger calculi. It is associated with success rates of more than
90% and with complication rates as low as 10%.
In a study which described 300 procedures of ureteric stone lithotripsy with holmium la‐
ser,  there was an overall  complication rate of 10%. Their overall  success rates were 90%
and after the first episode, 86% were stone free [21]. In another series of 598 patients, the
overall complication rate was 4%, with an overall the success rate of 97% and 94% after
the first episode [25].
5. Upper tract Transitional Cell Carcinoma (TCC) / malignancy
Upper tract TCC accounts for approximately 10% of all renal tumors and 5% of all urothelial
tumors. It is found to be more common in Caucasian, occurs more often in the sixth to sev‐
enth decade of life [26]. Worryingly there is evidence to suggest that the incidence of upper
tract TCC is increasing [27]. The presentation is usually with haematuria and approximately
30% will have “ureteric colic” secondary to blood clot [28]. They occur more commonly in
people with a history of bladder cancer.
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CT Urography is the standard diagnostic tool. However non-visualisation of lesions has
been reported in 20% of renal pelvis and 40% of ureteric tumors. Ureteroscopy (semi-rigid
or flexible) has been used to improve this accuracy as well as provide histological confirma‐
tion (figure 11). Williams et al have shown that ureteroscopic biopsy accurately predicts fi‐
nal histology at Nephro-ureterectomy in 75% of cases and further increases accuracy when
combined with exfoliative cytology (brushing the lesion with a brush passed endoscopical‐
ly) [29]. Ureteroscopic technique is as outlined before with the exception of use of a safety
wire. While a wire is used, it should be placed in the ureter under direct ureteroscopic vi‐
sion. This is because wire related urothelial trauma can mimic TCC and such trauma does
make cytological analysis more difficult.
Figure 11. Bigopty ®(Cook Medical) forceps removing a superficial TCC from the ureter.
Radical nephroureterectomy with an ipsi-lateral bladder cuff is still the gold standard treat‐
ment for upper tract TCC. Endourological management was initially introduced for those in
whom such radical procedure was not possible or who would have required dialysis post
operatively. However, the indications for endourological management increased with in‐
creased experience [30]. Now endourological management can be considered as potentially
curative for all bar those with high-grade or bulky lesions [31].
Because the indications for endoscopic management of upper tract TCC have expanded so
rapidly it is difficult to evaluate its efficacy. Potential markers of success are the subsequent
recurrence rate and the need for Nephro-ureterectomy.For tumors of the renal pelvis the re‐
currence rate is quite stable at 40%. This is not that dissimilar to bladder recurrences follow‐
ing endoscopic treatment of bladder TCC.However when looking at recurrences following
treatment of ureteric tumors the rates have increased from 14 up to 25% with a correspond‐
ing rise in rates of nephro-ureterectomy from 4 up to 14%. It is unclear whether this reflects
poor technique or the increasing expansion in use of ureteoscopy for upper tract TCC. As
alluded to above the best tumors are those of low grade, solitary and small with a papillary
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appearance with negative cytology [32]. From the point of view of laser choice the Holmium
is best for resection and Neodymium YAG is best for fulgaration.
6. Ureteric stricture / Pelvi-Ureteric Junction (PUJ) obstruction
PUJ obstruction is a functional blockage to antegrade flow of urine to the bladder from the
upper tract due to a narrowing at the PUJ. Its classically treated by an open (or laterally lap‐
aroscopic) procedure by the name of Pyeloplasty. Retrograde endopyelotomy is a minimally
invasive option.This is performed using a large calibre rigid ureterorenoresectoscope or us‐
ing a Holmium laser. The laser procedure is more common and usually linked with subse‐
quent balloon dilatation of the incised area. The incision is made laterally at the PUJ to
minimise vascular injury. The incision is deepened until peri-ureteric fat is seen. Balloon di‐
latation up to 24 F is then performed and a special stent inserted (Tapered with greater di‐
ameter at the top end) for six weeks. Longterm success rates of up to 77% have been
reported. Failure usually requires either open or laparoscopic pyeloplasty. A split function
of less than 20% and redundant renal pelvis are factors predictive of failure.
Ureteric strictures can also be treated with laser incision. For distal strictures the success
rates are of the order of 75% with an average follow-up of 3 years. Failures tend to occur
early [33]. Similar results are reported for mid-ureteric and proximal ureteric strictures. The
technique for ureteroscopic surgery is again incision to peri-ureteric fat but also includes in‐
cision into normal tissue either side of the stricture.
An alternative form of endo-urological stricture management is to use a combined balloon
dilator and Monopolar electrode. Identification of the stricture is radiological as once the
balloon is inflated with contrast, the stricture will be identified as an indentation on the bal‐
loon ie “waisting”. As the procedure is not visualised an adequate incision is identified as
contrast extravasation.
7. The future
There are now production models of video ureterorenoscopes. Their advantage is that they
are smaller, more manoeuvrable with a better picture and fluid flow rate. These instruments
use distal chip technology where the incoming light energy impacts on a digital chip. This
energy transfer results in a charge which is transmitted along a single fibre to a processor
which converts it into a usuable image.The better visual image is primarily due to less trans‐
mission loss. Energy (light) loss in fibreoptic ureteroscopes is multi-factorial but involves
cladding damage, damage to the fibre-optic bundles, light lead / connection damage and
camera head. It is primarily in the treatment of upper tract TCC where the improved imag‐
ing will be of most use. The increased magnification and resolution of the images together
with technology such as Narrow Band Imaging should expand the place of ureteroscopy in
the management of low grade upper tract TCC.
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8. Conclusion
The use of endo-urological techniques in day to day urological practice is increasing. This is
fuelled by many factors but amongst them is better technology, a greater number of trained
individuals and a desire to improve patient experience while maintaining outcomes. The fu‐
ture will be even better as better image definition becomes more readily available as video-
ureteroscopes become more durable.
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